<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran</PublisherName>
				<JournalTitle>TANAFFOS (Respiration)</JournalTitle>
				<Issn>1735-0344</Issn>
				<Volume>4</Volume>
				<Issue>4(autumn)</Issue>
				<PubDate PubStatus="epublish">
					<Year>2005</Year>
					<Month>12</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Evaluation of Patients with Infective Endocarditis in a Pulmonary Referral Centre</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>41</FirstPage>
			<LastPage>45</LastPage>
			<ELocationID EIdType="pii">241434</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Neda</FirstName>
					<LastName>Behzadnia</LastName>
<Affiliation>Cardiology Unit</Affiliation>
<Identifier Source="ORCID">0000-0001-8963-4285</Identifier>

</Author>
<Author>
					<FirstName>Payam</FirstName>
					<LastName>Tabarsi</LastName>
<Affiliation>Department of Infectious Diseases, NRITLD, Shaheed Beheshti University of Medical Sciences and Health Services,
TEHRAN-IRAN.</Affiliation>

</Author>
<Author>
					<FirstName>Babak Sharif</FirstName>
					<LastName>Kashani</LastName>
<Affiliation>Cardiology Unit</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Mehdi</FirstName>
					<LastName>Mirsaeidi</LastName>
<Affiliation>Department of Infectious Diseases, NRITLD, Shaheed Beheshti University of Medical Sciences and Health Services,
TEHRAN-IRAN.</Affiliation>

</Author>
<Author>
					<FirstName>Majid Valiollahpour</FirstName>
					<LastName>Amiri</LastName>
<Affiliation>Department of Infectious Diseases, NRITLD, Shaheed Beheshti University of Medical Sciences and Health Services,
TEHRAN-IRAN.</Affiliation>

</Author>
<Author>
					<FirstName>Anahita</FirstName>
					<LastName>Alvanpour</LastName>
<Affiliation>Department of Infectious Diseases, NRITLD, Shaheed Beheshti University of Medical Sciences and Health Services,
TEHRAN-IRAN.</Affiliation>

</Author>
<Author>
					<FirstName>Seyed Davood</FirstName>
					<LastName>Mansoori</LastName>
<Affiliation>Department of Infectious Diseases, NRITLD, Shaheed Beheshti University of Medical Sciences and Health Services,
TEHRAN-IRAN.</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2021</Year>
					<Month>01</Month>
					<Day>05</Day>
				</PubDate>
			</History>
		<Abstract>Background: Despite the decreased incidence of rheumatic fever and use of prophylactic antibiotic the incidence rate of&lt;br /&gt; infective endocarditis has not declined. In this research, we have studied the clinical feature and therapeutic response of&lt;br /&gt; patients with infective endocarditis presenting with pulmonary manifestations to a pulmonary referral center.&lt;br /&gt; Materials and Methods: All patients with diagnosis of endocarditis that had pulmonary manifestations (based on Duke&lt;br /&gt; Criteria) as their primary clinical presentation were entered in this study. Data in regard to individual information, clinical&lt;br /&gt; features, laboratory finding and therapeutic responses were noted. All data were analysed using SPSS software (version&lt;br /&gt; 11.5).&lt;br /&gt; Results: A total number of twenty patients here entered the study. Mean age was 34.8±11.6 yr. The commonest clinical&lt;br /&gt; features included: fever (95%), cough (65%) and dyspnea (65%). Also the commonest signs were cardiac murmurs (65%),&lt;br /&gt; hepatomegaly (35%) and splenomegaly (35%). Clubbing was seen in 10%. Sixty percent of the cases were intravenous drug&lt;br /&gt; users and 25% were infected with HIV. Also 50% of the patients did not have any background of valvular diseases. However,&lt;br /&gt; there was vegetations on one valve in 75% and multiple valves were involved in 25%. The commonest valves affected were&lt;br /&gt; trocuspid (50%), mitral (30%) and pulmonic valve (10%). Staphylococcus aureus (47.3%) and Streptococcus viridans&lt;br /&gt; (27.3%) were the commonest microorganisms detected. Pericardial effusion was present in 30% which was higher in IV drug&lt;br /&gt; users (p. value=0.042). Total mortality rate in hospital was 5%.&lt;br /&gt; Conclusion: Infective endocarditis should be considered in the list of differential diagnosis in patients suffering from&lt;br /&gt; pulmonary symptoms especially in IV drug users. (Tanaffos 2005; 4(16): 41-45)</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Endocarditis</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Intraverous drug user</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Valvular disease</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.tanaffosjournal.ir/article_241434_e613893fe934ebb86a637268b299d65c.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
